Live Broadcast to Explore a Treatment Option for EGFR Exon20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer

Article

In an upcoming live broadcast, Dr. Mark Socinski and Dr. Erminia Massarelli will discuss EGFR Exon20 insertion-positive non-small cell lung cancer and take a deeper look at current guideline-recommended testing. They will also talk about the safety and efficacy of a new option in patients previously treated with platinum-based chemotherapy. Additionally, they will discuss the implications of the data through a live question and answer session.

To obtain expert perspective and learn about how these results may affect your patients and your practice, watch the live broadcast on November 16th at 7PM ET or 9PM ET or November 17th at 12PM ET. To register for the event, visit https://studio.mjhassoc.com/reach/takedaonclivebroadcast.

USO-NON-0332 10/21

Related Videos
Arya Amini, MD
Vlad Gabriel Zaha, MD, PhD
Raj Singh, MD
Bruna Pellini, MD
Benjamin Levy, MD
Nisha A. Mohindra, MD, Northwestern University Feinberg School of Medicine
Jobelle Baldonado, MD
Joshua K. Sabari, MD, an expert on lung cancer, presenting slides
Chul Kim, MD, MPH
Salman R. Punekar, MD, Mayo Clinic